Navigation Links
Betsy McCaughey Responds to Poorly Informed Critics
Date:2/11/2009

NEW YORK, Feb. 12 /PRNewswire-USNewswire/ -- There has been enormous public controversy over the piece published on bloomberg.com (2/9/09) regarding health provisions in the President's stimulus bill. Betsy McCaughey, Ph.D. states:

1) While it is true that the office of the National Coordinator of Health Information Technology was created by former President Bush, that office provided a small advisory service for doctors and hospitals that voluntarily adopted electronic medical records. The stimulus bill transforms that small office into a vast bureaucracy with coercive powers that affect "every individual in the U.S."

2) Shame on the AARP for not recognizing the devastating impact of the Federal Council on Comparative Effectiveness Research, as proposed in the House bill (H.R.1.EH), on Medicare-eligible Americans. Fortunately, the Senate has now amended the measure of comparative effectiveness, removing cost effectiveness and replacing it only with clinical effectiveness. This eliminates a substantial threat to seniors. I applaud the Senate's change and urge the House to conform its legislation.

3) The major objections to the health provisions in the bill remain unanswered by critics. The provisions do not belong in a bill intended to jumpstart the economy. The sleight of hand proposed by Tom Daschle (pg. 196 of his book) to attach the broad outlines of healthcare change to a budget bill is undemocratic and deplorable. The Obama administration promised transparency. This is just the opposite. Americans deserve an open and honest debate about creating a federal healthcare infrastructure of this magnitude. These health provisions should be removed from the stimulus bill and offered to Congress in separate legislation.

Betsy McCaughey, Ph.D., is former Lt. Governor of New York State and Adjunct Fellow at the Hudson Institute, as well as Chairman/Founder of the Committee to Reduce Infection Deaths, an independent, non-profit patient advocacy organization.


'/>"/>
SOURCE Betsy McCaughey
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors
2. Zimmer Holdings Names Betsy Bernard to Board of Directors
3. Bioniche Responds to Australian Equine Influenza Outbreak
4. PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors
5. GlaxoSmithKline Responds to JAMA Articles
6. Common Good Responds to a Trial Bar Study Opposing Health Courts
7. Consumer Specialty Products Association Responds to European Study Investigating Spray Products and Asthma
8. DuPont Responds to Spelter, W.Va., Lawsuit Decision
9. MARCOR Responds to Deadly MRSA Outbreak
10. The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires
11. Cryolife Victim Responds to Untrue Assertions of Cryolife
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... SyncDog, Inc., ... of SentinelSecure™, version 3.0, will be available in a managed cloud services model, ... SentinelSecure™ comes with several new enhancements including support for caller ID and network ...
(Date:9/25/2017)... ... 2017 , ... Nissar A. Darmani, PhD, has been awarded a record WesternU ... nausea and vomiting. Dr. Darmani is Associate Dean of Basic Medical Sciences in ... is from the National Cancer Institute (NCI) arm of the National Institutes of Health ...
(Date:9/25/2017)... ... September 25, 2017 , ... Just ask anyone old enough to remember what ... headgear so wired up and containing so much metal that jokes about radio reception ... its treatments can barely be observed. As a result, it’s now a billion-dollar industry ...
(Date:9/25/2017)... ... September 25, 2017 , ... Winners in ... announced on Friday, September 22 during a gala event in New York City. ... achievements and HR-related products and suppliers who help to create and drive great ...
(Date:9/25/2017)... ... September 25, 2017 , ... How many things are on your average daily ... “more than any sane human could possibly complete,” then you’re all too familiar with ... desperately trying to be everything to everybody all the time. , Self-proclaimed overly productive ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BOTHELL, Wash. , Sept. 7, 2017   BioLife ... developer, manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), announces that Mike Rice , President and ... Rodman & Renshaw 19 th ... 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference ...
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
Breaking Medicine Technology: